ABBVIE INC.

ABBV · NEW YORK STOCK EXCHANGE INC.

Pharmaceutical Preparation Manufacturing · US

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

ESG Overview

Overall: BBB (High)

E: AS: BBG: BB

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $264.96 +3.13 (+1.20%)

Market Cap$443.23B

P/E Ratio70.24

EPS$—

52W High$267.47

52W Low$190.75

Beta0.22

Data from Finnhub · Updated Aug 24, 2026